Related Experiment Video
Updated: Jul 8, 2026
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
Anthony S Wierzbicki1, Scott D Purdon, Timothy C Hardman
1Department of Chemical Pathology, St. Thomas' Hospital, London, UK.
Current Medical Research and Opinion
|January 23, 2008
Summary
Highly active antiretroviral therapy (HAART) has improved HIV survival but can cause lipodystrophy, a condition with abnormal fat distribution and metabolic issues like insulin resistance. Management options are limited, highlighting the need for further research.
Area of Science:
- Endocrinology
- Infectious Diseases
- Metabolic Syndrome
Background:
- Highly active antiretroviral therapy (HAART) has dramatically improved outcomes for human immunodeficiency virus (HIV) infection since 1996.
- Increased life expectancy in HIV patients has brought chronic complications of HIV and HAART to the forefront.
Purpose of the Study:
- To provide an overview of HIV-associated lipodystrophy, including its pathogenesis and clinical consequences.
- To review the current understanding of lipodystrophy as a complication of HAART.
Main Methods:
- Literature search of PubMed for studies published up to November 2007.
- Review of existing research on HIV-associated lipodystrophy.
Main Results:
- HIV-associated lipodystrophy involves abnormal fat distribution and metabolic disturbances, including insulin resistance, dysregulated glucose and lipid metabolism.
- This syndrome increases the risk of type 2 diabetes and cardiovascular disease.
- Current management strategies are limited, focusing on risk factor avoidance and antiretroviral drug modification.
Conclusions:
- The increasing global implementation of HIV treatment strategies leads to a rise in patients on antiretroviral therapy.
- Awareness of potential metabolic complications, such as diabetes and cardiovascular disease, is crucial as these treatments reduce acute retroviral disease burden.
Related Concept Videos
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:31Lipid-derived Compounds in the Human Body
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...